Format

Send to

Choose Destination
Hum Genet. 2012 Mar;131(3):353-64. doi: 10.1007/s00439-011-1081-y. Epub 2011 Aug 20.

Sex differences in disease risk from reported genome-wide association study findings.

Author information

1
Division of Systems Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305-5415, USA. lyl@stanford.edu

Abstract

Men and women differ in susceptibility to many diseases and in responses to treatment. Recent advances in genome-wide association studies (GWAS) provide a wealth of data for associating genetic profiles with disease risk; however, in general, these data have not been systematically probed for sex differences in gene-disease associations. Incorporating sex into the analysis of GWAS results can elucidate new relationships between single nucleotide polymorphisms (SNPs) and human disease. In this study, we performed a sex-differentiated analysis on significant SNPs from GWAS data of the seven common diseases studied by the Wellcome Trust Case Control Consortium. We employed and compared three methods: logistic regression, Woolf's test of heterogeneity, and a novel statistical metric that we developed called permutation method to assess sex effects (PMASE). After correction for false discovery, PMASE finds SNPs that are significantly associated with disease in only one sex. These sexually dimorphic SNP-disease associations occur in Coronary Artery Disease and Crohn's Disease. GWAS analyses that fail to consider sex-specific effects may miss discovering sexual dimorphism in SNP-disease associations that give new insights into differences in disease mechanism between men and women.

PMID:
21858542
PMCID:
PMC3260375
DOI:
10.1007/s00439-011-1081-y
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center